MD Anderson at ESMO

New targeted therapy and immunotherapy approaches: Phase I clinical trial developments at ESMO Virtual Congress 2020

BRAF inhibitors and other targeted therapies, as well as a combination of chemotherapy and immunotherapy, are among the new treatments being tested through Phase I clinical trials. Learn about results shared by MD Anderson experts at ESMO Virtual Congress 2020.

Study challenges conventional understanding of signal from new diagnostic imaging technique

Magnetic resonance spectroscopy (MRS) offers potential advantages over the PET scan in providing information about a tumor's metabolic activity. But new research led by MD Anderson shows traditional interpretation of signals from that technique are incorrect.

Can lung cancer be stopped before it starts?

A first-of-its-kind immunoprevention clinical trial is testing whether an immunotherapy drug can prevent lung cancer in people at high risk for developing the disease. The drug helps the immune system track down and kill pre-cancer cells that may develop into lung cancer.